Safracin B (CAT#: ADCsR-230CL)
Safracin B is an novel antibiotic compound produced by Pseudomonas fluorescens. Safracin B showed antitumor activity against L1210 and P388 leukemias and B16 melanoma.Early research indicates that the alpha-carbinolamine structure may plays an important role in the antitumor action of this type of antibiotic.
Specific Inquiry
Specifications
- Synonyms
- Safracin B; Antibiotic EM 5519; Antibiotic Y 16482alpha; Antibiotic Y 16482-alpha; EM 5519; Propanamide, 2-amino-N-((6,7,9,10,13,14,14a,15-octahydro-1,7-dihydroxy-2,11-dimethoxy-3,12,16-trimethyl-10,13-dioxo-6,15-imino-5H-isoquino(3,2-b)(3)benzazocin-9-yl
- Formula
- C28H36N4O7
- CAS No.
- 87578-99-2
- Molecular Weight
- 540,61 g/mol
- Purity
- 95%
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for ADCsR-230CL. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: Inhib, Cyt
Application: Neut, ELISA, IF, IP, FuncS, FC, WB
Application: IHC, ELISA, FC, WB, ADCC, FuncS
Application: WB, ELISA, IF
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: Neut
Application: Neut
Application: ELISA, IHC, IF, IP
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.